7-HYDROXY-METHOTREXATE AND CLINICAL TOXICITY FOLLOWING HIGH-DOSE METHOTREXATE THERAPY

被引：13

作者：

ERTTMANN, R

BIELACK, S

LANDBECK, G

机构：

来源：

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1985年 / 109卷 / 01期

关键词：

D O I：

10.1007/BF01884261

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：86 / 88

页数：3

共 8 条

[1]

BREITHAUPT H, 1982, CANCER TREAT REP, V66, P1733

[2]

ERTTMANN R, 1984, Naunyn-Schmiedeberg's Archives of Pharmacology, V325, pR88

[3] SYNTHESIS AND BIOLOGIC EVALUATION OF 7-HYDROXYMETHOTREXATE, 7-METHYLAMINOPTERIN, AND 7-METHYLMETHOTREXATE [J].

FARQUHAR, D ;

LOO, TL .

JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (05) :567-&

[4]

JACOBS SA, 1977, CANCER TREAT REP, V61, P651

[5] THE ROLE OF 7-HYDROXYMETHOTREXATE DURING METHOTREXATE ANTI-CANCER THERAPY [J].

LANKELMA, J ;

VANDERKLEIN, E ;

RAMAEKERS, F .

CANCER LETTERS, 1980, 9 (02) :133-142

[6]

Perez C, 1978, Cancer Clin Trials, V1, P107

[7]

PRZBYLSKI M, 1982, BIOMED MASS SPECTROM, V9, P22

[8] ADJUVANT CHEMOTHERAPY IN OSTEO-SARCOMA - EFFECTS OF CISPLATINUM, BCD, AND FIBROBLAST INTERFERON IN SEQUENTIAL COMBINATION WITH HD-MTX AND ADRIAMYCIN - PRELIMINARY-RESULTS OF THE COSS-80 STUDY [J].

WINKLER, K ;

BERON, G ;

KOTZ, R ;

SALZERKUNTSCHIK, M ;

BECK, J ;

BECK, W ;

BRANDEIS, W ;

EBELL, W ;

ERTTMANN, R ;

GOBEL, U ;

HAVERS, W ;

HENZE, G ;

HINDERFELD, L ;

HOCKER, P ;

JOBKE, A ;

JURGENS, H ;

KABISCH, H ;

LANDBECK, G ;

PREUSSER, P ;

PRINDULL, G ;

RAMACH, W ;

RITTER, J ;

SEKERA, J ;

TREUNER, J ;

WUST, G .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 106 :1-7

← 1 →